Your Health, We Care
Kidney International has released Phase 2 clinical study 1 of sparsentan, in which blood pressure was well controlled in all patients.
Sparsentan is a type of factor B inhibitor that has complement inhibitory effects and has relatively little impact on the immune and endocrine systems. It has a relatively low risk of serious adverse events and may be used to treat IgA nephropathy.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
